Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimensAndrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology|January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experienceMattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
BMC Cancer|October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell deathFrancesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Hematological Oncology|September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literatureAndrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
Cancer Cell International|January 26, 2025
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancerElena Lastraioli, Jessica Iorio, Francesco Piazza, et al.
Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Frontiers in Oncology|September 20, 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVDAlessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, et al.
Cancers|March 28, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease CourseFrancesco Angotzi, Alessandro Cellini, Valeria Ruocco, et al.
Pageof 26